Clear Cell
Sarcomas

NF2-mutant / YAP-Fusion
Cancers

KEAP1-mutant
Lung Cancers


MCTO
(Rare Disease)

Partner with
Arpeggio

Arpeggio is a team of leading experts in disease biology and drug discovery research. Our pipeline of unique small-molecule inhibitors were designed to probe biology on a systems level, getting to the heart of disease sooner.

Partner With Us

Contact Us

Have questions? Interested in partnering with Arpeggio? Let us know.

Your message has been submitted.
We will get back to you within 24-48 hours.
Oops! Something went wrong.